Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy

Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy

Transthyretin cardiac amyloidosis (ATTR-CA) has been traditionally considered a rare and inexorably fatal condition. ATTR-CA now is an increasingly recognised cause of heart failure and mortality worldwide with effective pharmacological treatments. Advances in non-invasive diagnosis, coupled with th...

Full description

Bibliographic Details
Main Authors: Marianna Fontana, Aldostefano Porcari, Philip N. Hawkins
Format: Article
Language:English
Published: Ubiquity Press 2023-11-01
Series:Global Heart
Subjects:
cardiac amyloidosis
transthyretin
diagnosis
treatment
prognosis
Online Access:https://account.globalheartjournal.com/index.php/up-j-gh/article/view/1275

Similar Items

Similar Items